Skip to main content

Table 3 Comparison between serum biomarker concentrations on day 2 of aSAH and at time of CV

From: Role of serum biomarkers and transcranial Doppler in predicting cerebral vasospasm after aneurysmal subarachnoid hemorrhage

Serum biomarkers of CV groupDay 2At time of detection of CVPaired t testp value
vWF (ng/ml)
 Mean ± SD6613.26 ± 1580.236901.89 ± 1546.96− 2.9200.009
 Range4540–a94214798–a9460
VEGF (pg/ml)
 Mean ± SD271.68 ± 92.93329.62 ± 81.19− 2.0470.048
 Range62.9–a413116–a420
MMP-9 (ng/ml)
 Mean ± SD798.11 ± 145.97830.84 ± 129.85− 4.289< 0.001
 Range510–a1000540–a994
  1. aSAH aneurysmal subarachnoid hemorrhage, CV cerebral vasospasm (ml), MMP-9 matrix metalloproteinase-9, ng/ml nanograms per milliliter, pg/ml picogram per milliliter, SD standard deviation, VEGF vascular endothelial growth factor, vWF von Willebrand factor